US Congress considers 'Netflix for antibiotics' funding model

A bill to de-link antimicrobial innovation funding from volume and instead rely on fixed-rate funding for new drugs is gaining momentum in Washington, building off similar successful programs in the UK...

Already a subscriber? Click here to view full article